Erythema multiforme (EM) is a rare skin condition that is characterized by an itchy rash that appears on the skin in the form of red patches, bumps, or blisters. It is usually caused by an allergic reaction to a medication or infection, but can also be caused by an autoimmune disorder. The condition can be mild or severe, and it can affect people of any age. While the rash can be painful and uncomfortable, it is usually not serious and can be treated with over-the-counter medications or topical creams. In this article, we will provide a visual guide to erythema multiforme, including what it looks like, the symptoms associated with it, and the treatment options available.
Erythema multiforme typically appears as red patches, bumps, or blisters on the skin. The rash can appear anywhere on the body, but is most commonly found on the hands, feet, and face. The rash can range in size from a few millimeters to several centimeters in diameter. It is usually symmetrical, meaning that it appears on both sides of the body. The rash is usually itchy and can be painful or tender to the touch. The rash can also have a “target” or “bull’s-eye” appearance, with a central red area surrounded by a ring of paler red. This is known as the “iris” pattern and is a characteristic of erythema multiforme. In some cases, the rash may also have a purplish or bluish hue.
In addition to the rash, erythema multiforme can also cause other symptoms, including fever, chills, sore throat, and fatigue. In some cases, the rash may be accompanied by eye irritation, such as redness, swelling, and pain. It is important to note that erythema multiforme is not contagious and cannot be spread from person to person.
Erythema multiforme is usually caused by an allergic reaction to a medication or infection. Common triggers include antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs), and anticonvulsants. In some cases, the condition can be caused by an autoimmune disorder, such as lupus or Sjogren’s syndrome.
Erythema multiforme is usually diagnosed based on the appearance of the rash. Your doctor may also take a skin sample (biopsy) to confirm the diagnosis. In some cases, blood tests may be used to rule out other conditions that may be causing the rash.
The treatment of erythema multiforme depends on the severity of the condition. Mild cases may be treated with over-the-counter medications, such as antihistamines, or topical creams. In more severe cases, your doctor may prescribe oral steroids or other medications to reduce inflammation and itching.
Erythema multiforme is a rare skin condition that is characterized by an itchy rash that appears on the skin in the form of red patches, bumps, or blisters. It is usually caused by an allergic reaction to a medication or infection, but can also be caused by an autoimmune disorder. While the rash can be painful and uncomfortable, it is usually not serious and can be treated with over-the-counter medications or topical creams. This article provided a visual guide to erythema multiforme, including what it looks like, the symptoms associated with it, and the treatment options available.
1.
New drug combination shows good results in patients with HPV-negative head and neck cancer
2.
Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC
3.
No increased risk of childhood cancer near UK nuclear sites, study finds
4.
Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD
5.
Spicy Chip Death Lawsuit; Gen X and Cancer; Extreme U.S. Temperatures
1.
Revolutionizing Cancer Treatment: How Adoptive Cell Therapy is Overcoming Tumor Immune Evasion
2.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
3.
An Overview Of Daunorubicin: What Is It Used For And How Does It Work?
4.
HSC Failure in Fanconi Anemia: Mechanisms, Models, and Emerging Therapeutic Pathways
5.
General Practitioners Role in Diagnosing Ovarian Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
4.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation